Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7863740 | 1.00 | TSHR (0.47) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL30787320 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL28933824 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL30787420 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL4442974 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL7756309 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL6842053 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL30787261 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL6279129 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 | |
| SCHEMBL11314333 | 0.97 | TSHR (0.45) | TSHRGPR84FFAR4FFAR1PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | claimed |
| CN-1401710-A | Ink composition with high ink bleeding prevention | BENQ CORP (CN) | 2003-03-12 | — | — | CN | claimed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | claimed |
| US-6310003-B1 | Composition of chemicals for manipulating the behavior of the orange wheat blossom midge, sitodiplosis mosellana (Géhin) | SIMON FRASER UNIVERSITY (CA) | 2001-10-30 | — | — | US | claimed |
| EP-4554379-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | Apeo - Agronomical Plant Extracts & Essential Oils (BE) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024013148-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO – AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2024-01-18 | — | — | WO | disclosed |
| CN-111278821-B | Spiro compounds as farnesol X receptor modulators | 百时美施贵宝公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116583285-A | N- (imidazo [1,2-b ] pyridazin-3-yl) -1-cyclohexyl-2H-indazole-5-carboxamide and N- (pyrazolo [1,5-a ] pyrimidin-3-yl) -1-cyclohexyl-2H-indazole-5-carboxamide derivatives as IRAK4 inhibitors for the treatment of asthma | 阿斯利康(瑞典)有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-111278821-A | Spiro compounds as farnesoid X receptor modulators | 百时美施贵宝公司 | 2020-06-12 | — | — | CN | disclosed |
| CN-103880823-B | Application as the spiro-compound of hepatitis c inhibitor and its in medicine | 广东东阳光药业有限公司 | 2017-12-05 | — | — | CN | disclosed |
| CN-104003980-B | It is used as the endocyclic compound and its pharmaceutical composition and purposes of hepatitis c inhibitor | 广东东阳光药业有限公司 | 2017-08-08 | — | — | CN | disclosed |
| EP-2700636-B1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2017-08-02 | — | — | EP | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| CN-101519552-B | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2011-08-24 | — | — | CN | disclosed |
| CN-101519552-A | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2009-09-02 | — | — | CN | disclosed |
| US-20050143599-A1 | Process for preparing monoesters | 3M INNOVATIVE PROPERTIES COMPANY | 2005-06-30 | — | — | US | disclosed |
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | disclosed |
| CN-1401710-A | Ink composition with high ink bleeding prevention | BENQ CORP (CN) | 2003-03-12 | — | — | CN | disclosed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | disclosed |
| US-6310003-B1 | Composition of chemicals for manipulating the behavior of the orange wheat blossom midge, sitodiplosis mosellana (Géhin) | SIMON FRASER UNIVERSITY (CA) | 2001-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143599-A1 | Process for preparing monoesters | ADSL, COASY, AGPS | TSHR 4761/4885GPR84 1658/4885FFAR4 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.